Retour
42
Fourchette du Jour
11,00 €
11,00 €
Fourchette 52 Semaines
9,50 €
18,55 €
Volume
130
Moyenne 50J / 200J
12,38 €
/
14,80 €
Clôture Précédente
11,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -0,3 | 0,4 |
| P/B | 0,2 | 2,9 |
| ROE % | -46,6 | 3,7 |
| Net Margin % | -145,7 | 3,8 |
| Rev Growth 5Y % | 19,6 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue grew 19,61% annually over 5 years — strong growth
Earnings declined -1077,00% over the past year
Debt/Equity of 0,20 — conservative balance sheet
Generating 343,10M in free cash flow
PEG of 0,00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 24,29%
Croissance
Revenue Growth (5Y)
19,61%
Revenue (1Y)-4,68%
Earnings (1Y)-1077,00%
FCF Growth (3Y)-26,67%
Qualité
Return on Equity
-46,55%
ROIC4,57%
Net Margin-145,70%
Op. Margin16,83%
Sécurité
Debt / Equity
0,20
Current Ratio3,40
Interest Coverage12,08
Valorisation
P/E Ratio
-0,30
P/B Ratio0,19
EV/EBITDA3,95
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,68% | Revenue Growth (3Y) | -1,03% |
| Earnings Growth (1Y) | -1077,00% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19,61% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,44B | Net Income (TTM) | -5,01B |
| ROE | -46,55% | ROA | -45,06% |
| Gross Margin | 58,05% | Operating Margin | 16,83% |
| Net Margin | -145,70% | Free Cash Flow (TTM) | 343,10M |
| ROIC | 4,57% | FCF Growth (3Y) | -26,67% |
| Safety | |||
| Debt / Equity | 0,20 | Current Ratio | 3,40 |
| Interest Coverage | 12,08 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | -0,30 | P/B Ratio | 0,19 |
| P/S Ratio | 0,43 | PEG Ratio | 0,00 |
| EV/EBITDA | 3,95 | Dividend Yield | 0,01% |
| Market Cap | 1,49B | Enterprise Value | 2,29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,44B | 3,61B | 3,51B | 3,23B | 1,68B |
| Net Income | -5,01B | 513,00M | -3,85B | 394,00M | 341,00M |
| EPS (Diluted) | -34,79 | 3,78 | -28,44 | 2,91 | 2,97 |
| Gross Profit | 2,00B | 2,14B | 1,98B | 1,78B | 1,05B |
| Operating Income | 579,03M | 783,00M | -3,59B | 654,00M | 435,38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11,12B | 17,45B | 16,33B | 20,55B | 19,43B |
| Total Liabilities | 3,23B | 3,81B | 3,61B | 3,81B | 4,09B |
| Shareholders' Equity | 7,89B | 13,64B | 12,72B | 16,74B | 15,32B |
| Total Debt | 1,61B | 2,09B | 2,09B | 2,23B | 2,48B |
| Cash & Equivalents | 809,00M | 1,14B | 861,00M | 578,00M | 630,09M |
| Current Assets | 2,09B | 2,36B | 1,91B | 1,57B | 1,41B |
| Current Liabilities | 615,00M | 705,00M | 557,00M | 621,00M | 954,33M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#412 of 820
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026